渣甸山衛信道豪宅「松圃」獲財團以逾11億元收購
據土地註冊處資料,渣甸山衛信道豪宅「松圃」近日錄得多宗二手成交,總成交價逾11.1億元,每呎樓面地價逾4萬元,預料為財團收購個案,新買家騰豐企業有限公司,據報或與恆地(00012.HK)相關。
「松圃」位於衛信道8至12A號,為1座於1965年落成的樓宇。項目最新錄得17宗住宅連17個車位的二手成交,總成交價逾11.1億元,該批單位實用面積約1,216至1,547平方呎,成交價介乎約5,958.4萬至7,580.3萬元。據報該物業尚餘1伙未收購。
物業所在地盤面積約3.7萬平方呎,相關用地最高地積比率為0.75倍,未來最高可建樓面面積約2.78萬平方呎。
新買家騰豐企業的董事羅泰安,過往多次為恆地進行收購。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.